HANDOK Inc. (002390.KS)

KRW 12270.0

(-2.54%)

Net Income Summary of HANDOK Inc.

  • HANDOK Inc.'s latest annual net income in 2023 was -28.79 Billion KRW , down -369.55% from previous year.
  • HANDOK Inc.'s latest quarterly net income in 2024 Q2 was -12.88 Billion KRW , down -472.22% from previous quarter.
  • HANDOK Inc. reported an annual net income of 10.68 Billion KRW in 2022, up 224.25% from previous year.
  • HANDOK Inc. reported an annual net income of 3.29 Billion KRW in 2021, down -87.78% from previous year.
  • HANDOK Inc. reported a quarterly net income of -2.25 Billion KRW for 2024 Q1, up 85.28% from previous quarter.
  • HANDOK Inc. reported a quarterly net income of -12.88 Billion KRW for 2024 Q2, down -472.22% from previous quarter.

Annual Net Income Chart of HANDOK Inc. (2023 - 2007)

Historical Annual Net Income of HANDOK Inc. (2023 - 2007)

Year Net Income Net Income Growth
2023 -28.79 Billion KRW -369.55%
2022 10.68 Billion KRW 224.25%
2021 3.29 Billion KRW -87.78%
2020 26.95 Billion KRW -22.82%
2019 34.92 Billion KRW 337.18%
2018 7.98 Billion KRW 64.11%
2017 4.86 Billion KRW 175.43%
2016 -6.45 Billion KRW -282.54%
2015 -1.68 Billion KRW -214.52%
2014 1.47 Billion KRW -88.03%
2013 12.3 Billion KRW 113.4%
2012 5.76 Billion KRW -65.2%
2011 16.57 Billion KRW -19.27%
2010 20.53 Billion KRW 14.02%
2009 18 Billion KRW 163.77%
2008 6.82 Billion KRW -64.4%
2007 19.17 Billion KRW 0.0%

Peer Net Income Comparison of HANDOK Inc.

Name Net Income Net Income Difference
Yuyu Pharma, Inc. -7.18 Billion KRW -301.028%
Dong-A Socio Holdings Co., Ltd. 57.98 Billion KRW 149.66%
Ildong Holdings Co., Ltd. -59.58 Billion KRW 51.671%
Kukje Pharma Co., Ltd. -8.41 Billion KRW -242.208%
Yuhan Corporation 93.5 Billion KRW 130.796%
Dong-A ST Co., Ltd. 11.12 Billion KRW 358.912%
SAMSUNG PHARM. Co., LTD. -24.81 Billion KRW -16.062%
Hanmi Pharm. Co., Ltd. 146.23 Billion KRW 119.693%
Hanall Biopharma Co.,Ltd 3.5 Billion KRW 920.766%
Ilyang Pharmaceutical Co.,Ltd -2.5 Billion KRW -1048.95%
Dong Sung Bio Pharm.Co.,Ltd. -2.07 Billion KRW -1288.558%
MYUNGMOON Pharm co.,Ltd -4.52 Billion KRW -536.431%
Hana Pharm Co., Ltd. 22.33 Billion KRW 228.947%
Yuyu Pharma, Inc. -7.18 Billion KRW -301.028%
Ilsung Pharmaceuticals Co., Ltd. -20.94 Billion KRW -37.518%
REYON Pharmaceutical Co., Ltd. 3.58 Billion KRW 903.641%
Aprogen pharmaceuticals,Inc. -118.26 Billion KRW 75.651%
JW Holdings Corporation 19.02 Billion KRW 251.356%
Ildong Pharmaceutical Co., Ltd. -78.92 Billion KRW 63.514%
Chong Kun Dang Pharmaceutical Corp. 212.52 Billion KRW 113.55%
JW Pharmaceutical Corporation 37 Billion KRW 177.818%
Shin Poong Pharm.Co.,Ltd. -57.32 Billion KRW 49.765%
Hyundai Pharmaceutical Co., Ltd. 6.12 Billion KRW 570.411%
Samil Pharmaceutical Co.,Ltd 1.66 Billion KRW 1831.095%
Jeil Pharmaceutical Co.,Ltd 5 Billion KRW 675.403%
Yuyu Pharma, Inc. -7.18 Billion KRW -301.028%
Kwang Dong Pharmaceutical Co., Ltd. 36.96 Billion KRW 177.903%
Daewoong pharmaceutical Co.,Ltd 111.5 Billion KRW 125.827%
JW Pharmaceutical Corporation 37 Billion KRW 177.818%
Yuhan Corporation 93.5 Billion KRW 130.796%
Jeil Pharma Holdings Inc -16.24 Billion KRW -77.218%
Yungjin Pharm. Co., Ltd. -3.87 Billion KRW -643.056%
Suheung Co., Ltd. 6.11 Billion KRW 570.606%
JW Pharmaceutical Corporation 37 Billion KRW 177.818%
Samjin Pharmaceuticals Co., Ltd. 18.9 Billion KRW 252.321%
Korea United Pharm Inc. 48.26 Billion KRW 159.669%
CKD Bio Corp. -24.19 Billion KRW -19.035%
Daewon Pharmaceutical Co., Ltd. 23.91 Billion KRW 220.406%
Dongwha Pharm.Co.,Ltd 27.43 Billion KRW 204.954%
Whan In Pharm Co.,Ltd. 29.77 Billion KRW 196.719%
Shin Poong Pharm.Co.,Ltd. -57.32 Billion KRW 49.765%
Chong Kun Dang Holdings Corp. 47 Billion KRW 161.261%
Boryung Corporation 40.2 Billion KRW 171.63%
Bukwang Pharmaceutical Co., Ltd. -31.32 Billion KRW 8.082%
Ilyang Pharmaceutical Co.,Ltd -2.5 Billion KRW -1048.95%
JW Lifescience Corporation 28.14 Billion KRW 202.322%